Arete Wealth Advisors’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-733	Closed	-$35K	–	685
2022 Q3	$35K	Buy	+733	New	+$35K	﹤0.01%	563
2022 Q2	–	Sell	-733	Closed	-$59K	–	525
2022 Q1	$59K	Buy	+733	New	+$59K	﹤0.01%	497